Effect of COVID-19 on anakinra-induced remission in homozygous STX11 hemophagocytosis lymphohistiocytosis

Pediatr Blood Cancer. 2021 Jun;68(6):e28897. doi: 10.1002/pbc.28897. Epub 2021 Jan 14.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / therapeutic use*
  • COVID-19 / complications*
  • COVID-19 Drug Treatment
  • Child, Preschool
  • Frameshift Mutation
  • Homozygote
  • Humans
  • Interleukin 1 Receptor Antagonist Protein / administration & dosage
  • Interleukin 1 Receptor Antagonist Protein / therapeutic use*
  • Lymphohistiocytosis, Hemophagocytic / complications*
  • Lymphohistiocytosis, Hemophagocytic / drug therapy*
  • Lymphohistiocytosis, Hemophagocytic / genetics
  • Male
  • Qa-SNARE Proteins / genetics*
  • SARS-CoV-2 / isolation & purification

Substances

  • Anti-Inflammatory Agents
  • Interleukin 1 Receptor Antagonist Protein
  • Qa-SNARE Proteins
  • STX11 protein, human